Neuberger Berman Group’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.27M | Buy |
3,821
+99
| +3% | +$49.3K | ﹤0.01% | 1151 |
|
|
2025
Q4 | $1.81M | Buy |
3,722
+575
| +18% | +$268K | ﹤0.01% | 1211 |
|
|
2025
Q3 | $1.32M | Buy |
3,147
+306
| +11% | +$103K | ﹤0.01% | 1279 |
|
|
2025
Q2 | $816K | Sell |
2,841
-492
| -15% | -$147K | ﹤0.01% | 1422 |
|
|
2025
Q1 | $1.03M | Buy |
3,333
+119
| +4% | +$40.8K | ﹤0.01% | 1307 |
|
|
2024
Q4 | $1.13M | Buy |
3,214
+44
| +1% | +$16.2K | ﹤0.01% | 1278 |
|
|
2024
Q3 | $1.14M | Buy |
3,170
+26
| +0.8% | +$8.78K | ﹤0.01% | 1264 |
|
|
2024
Q2 | $1M | Buy |
3,144
+253
| +9% | +$67K | ﹤0.01% | 1284 |
|
|
2024
Q1 | $664K | Buy |
2,891
+179
| +7% | +$40.4K | ﹤0.01% | 1399 |
|
|
2023
Q4 | $596K | Buy |
2,712
+197
| +8% | +$45.4K | ﹤0.01% | 1438 |
|
|
2023
Q3 | $568K | Buy |
2,515
+71
| +3% | +$16.4K | ﹤0.01% | 1422 |
|
|
2023
Q2 | $540K | Buy |
2,444
+527
| +27% | +$117K | ﹤0.01% | 1421 |
|
|
2023
Q1 | $429K | Buy |
1,917
+41
| +2% | +$10.1K | ﹤0.01% | 1504 |
|
|
2022
Q4 | $522K | Buy |
1,876
+10
| +0.5% | +$2.52K | ﹤0.01% | 1441 |
|
|
2022
Q3 | $391K | Buy |
1,866
+3
| +0.2% | +$671 | ﹤0.01% | 1536 |
|
|
2022
Q2 | $439K | Buy |
1,863
+67
| +4% | +$13.6K | ﹤0.01% | 1527 |
|
|
2022
Q1 | $322K | Buy |
+1,796
| New | +$342K | ﹤0.01% | 1673 |
|
|
2021
Q3 | – | Sell |
-2,171
| Closed | -$348K | – | 1824 |
|
|
2021
Q2 | $348K | Sell |
2,171
-217
| -9% | -$41.3K | ﹤0.01% | 1567 |
|
|
2021
Q1 | $361K | Buy |
+2,388
| New | +$398K | ﹤0.01% | 1563 |
|
|
2018
Q2 | – | Sell |
-2,147
| Closed | -$241K | – | 1760 |
|
|
2018
Q1 | $241K | Sell |
2,147
-623
| -22% | -$79.1K | ﹤0.01% | 1565 |
|
|
2017
Q4 | $410K | Buy |
2,770
+500
| +22% | +$63.6K | ﹤0.01% | 1453 |
|
|
2017
Q3 | $266K | Buy |
2,270
+86
| +4% | +$11K | ﹤0.01% | 1445 |
|
|
2017
Q2 | $283K | Sell |
2,184
-2,739
| -56% | -$342K | ﹤0.01% | 1425 |
|
|
2017
Q1 | $666K | Buy |
4,923
+915
| +23% | +$139K | ﹤0.01% | 1233 |
|
|
2016
Q4 | $575K | Buy |
4,008
+2,038
| +103% | +$260K | ﹤0.01% | 1265 |
|
|
2016
Q3 | $233K | Buy |
+1,970
| New | +$237K | ﹤0.01% | 1470 |
|
|
2015
Q3 | – | Sell |
-154,650
| Closed | -$26.9M | – | 1586 |
|
|
2015
Q2 | $26.9M | Sell |
154,650
-9,689
| -6% | -$1.74M | 0.03% | 598 |
|
|
2015
Q1 | $28.3M | Buy |
164,339
+68,539
| +72% | +$10.4M | 0.03% | 586 |
|
|
2014
Q4 | $12.4M | Buy |
95,800
+45,200
| +89% | +$5.82M | 0.01% | 787 |
|
|
2014
Q3 | $6.51M | Buy |
+50,600
| New | +$5.22M | 0.01% | 918 |
|
|
2014
Q2 | – | Sell |
-3,000
| Closed | -$282K | – | 1756 |
|
|
2014
Q1 | $282K | Hold |
3,000
| – | – | ﹤0.01% | 1455 |
|
|
2013
Q4 | $339K | Hold |
3,000
| – | – | ﹤0.01% | 1407 |
|
|
2013
Q3 | $237K | Buy |
+3,000
| New | +$219K | ﹤0.01% | 1477 |
|
Other funds holding UTHR
ACA
VPM
VCM
